Results: 1-23 |
Results: 23

Authors: Aronow, BJ Toyokawa, T Canning, A Haghighi, K Delling, U Kranias, E Molkentin, JD Dorn, GW
Citation: Bj. Aronow et al., Divergent transcriptional responses to independent genetic causes of cardiac hypertrophy, PHYSIOL GEN, 6(1), 2001, pp. 19-28

Authors: Molkentin, JD Dorn, GW
Citation: Jd. Molkentin et Gw. Dorn, Cytoplasmic signaling pathways that regulate cardiac hypertrophy, ANN R PHYSL, 63, 2001, pp. 391-426

Authors: Chen, L Hahn, H Wu, GY Chen, CH Liron, T Schechtman, D Cavallaro, G Banci, L Guo, YR Bolli, R Dorn, GW Mochly-Rosen, D
Citation: L. Chen et al., Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC, P NAS US, 98(20), 2001, pp. 11114-11119

Authors: Rogers, JH Tsirka, A Kovacs, A Blumer, KJ Dorn, GW Muslin, AJ
Citation: Jh. Rogers et al., RGS4 reduces contractile dysfunction and hypertrophic gene induction in G(alpha q) overexpressing mice, J MOL CEL C, 33(2), 2001, pp. 209-218

Authors: Haghighi, K Schmidt, AG Hoit, B Brittsan, AG Yatani, A Lester, JW Zhai, J Kimura, Y Dorn, GW MacLennan, DH Kranias, EG
Citation: K. Haghighi et al., Superinhibition of sarcoplasmic reticulum function by phospholamban induces cardiac contractile failure, J BIOL CHEM, 276(26), 2001, pp. 24145-24152

Authors: Sato, Y Kiriazis, H Yatani, A Schmidt, AG Hahn, H Ferguson, DG Sako, H Mitarai, S Honda, R Mesnard-Rouiller, L Frank, KF Beyermann, B Wu, GY Fujimori, K Dorn, GW Kranias, EG
Citation: Y. Sato et al., Rescue of contractile parameters and myocyte hypertrophy in calsequestrin overexpressing myocardium by phospholamban ablation, J BIOL CHEM, 276(12), 2001, pp. 9392-9399

Authors: Dorn, GW
Citation: Gw. Dorn, Calcineurin inhibition in hypertrophy - Back from the dead!, CIRCULATION, 104(1), 2001, pp. 9-11

Authors: Dash, R Kadambi, VJ Schmidt, AG Tepe, NM Biniakiewicz, D Gerst, MJ Canning, AM Abraham, WT Hoit, BD Liggett, SB Lorenz, JN Dorn, GW Kranias, EG
Citation: R. Dash et al., Interactions between phospholamban and beta-adrenergic drive may lead to cardiomyopathy and early mortality, CIRCULATION, 103(6), 2001, pp. 889-896

Authors: Wang, XJ Osinska, H Dorn, GW Nieman, M Lorenz, JN Gerdes, AM Witt, S Kimball, T Gulick, J Robbins, J
Citation: Xj. Wang et al., Mouse model of desmin-related cardiomyopathy, CIRCULATION, 103(19), 2001, pp. 2402-2407

Authors: Robbins, J Dorn, GW
Citation: J. Robbins et Gw. Dorn, Listening for hoof beats in heart beats, NAT MED, 6(9), 2000, pp. 968-970

Authors: Dorn, GW Tepe, NM Wu, GY Yatani, A Liggett, SB
Citation: Gw. Dorn et al., Mechanisms of impaired beta-adrenergic receptor signaling in G(alpha q)-mediated cardiac hypertrophy and ventricular dysfunction, MOLEC PHARM, 57(2), 2000, pp. 278-287

Authors: Wu, GY Toyokawa, T Hahn, H Dorn, GW
Citation: Gy. Wu et al., epsilon Protein kinase C in pathological myocardial hypertrophy - Analysisby combined transgenic expression of translocation modifiers and G alpha(q), J BIOL CHEM, 275(39), 2000, pp. 29927-29930

Authors: Wagoner, LE Craft, LL Singh, B Suresh, DP Zengel, PW McGuire, N Abraham, WT Chenier, TC Dorn, GW Liggett, SB
Citation: Le. Wagoner et al., Polymorphisms of the beta(2)-adrenergic receptor determine exercise capacity in patients with heart failure, CIRCUL RES, 86(8), 2000, pp. 834-840

Authors: De Windt, LJ Lim, HW Taigen, T Wencker, D Condorelli, G Dorn, GW Kitsis, RN Molkentin, JD
Citation: Lj. De Windt et al., Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis invitro and in vivo - An apoptosis-independent model of dilated heart failure, CIRCUL RES, 86(3), 2000, pp. 255-263

Authors: Mochly-Rosen, D Wu, GY Hahn, H Osinska, H Liron, T Lorenz, JN Yatani, A Robbins, J Dorn, GW
Citation: D. Mochly-rosen et al., Cardiotrophic effects of protein kinase C epsilon - Analysis by in vivo modulation of PKC epsilon translocation, CIRCUL RES, 86(11), 2000, pp. 1173-1179

Authors: Liggett, SB Tepe, NM Lorenz, JN Canning, AM Jantz, TD Mitarai, S Yatani, A Dorn, GW
Citation: Sb. Liggett et al., Early and delayed consequences of beta(2)-adrenergic receptor overexpression in mouse hearts - Critical role for expression level, CIRCULATION, 101(14), 2000, pp. 1707-1714

Authors: Dorn, GW Brown, JH
Citation: Gw. Dorn et Jh. Brown, Gq signaling in cardiac adaptation and maladaptation, TREND CARD, 9(1-2), 1999, pp. 26-34

Authors: Dorn, GW Souroujon, MC Liron, T Chen, CH Gray, MO Zhou, HZ Csukai, M Wu, GY Lorenz, JN Mochly-Rosen, D
Citation: Gw. Dorn et al., Sustained in vivo cardiac protection by a rationally designed peptide thatcauses epsilon protein kinase C translocation, P NAS US, 96(22), 1999, pp. 12798-12803

Authors: Dorn, GW Tepe, NM Lorenz, JN Koch, WJ Liggett, SB
Citation: Gw. Dorn et al., Low- and high-level transgenic expression of beta(2)-adrenergic receptors differentially affect cardiac hypertrophy and function in G alpha q-overexpressing mice, P NAS US, 96(11), 1999, pp. 6400-6405

Authors: Yatani, A Frank, K Sako, H Kranias, EG Dorn, GW
Citation: A. Yatani et al., Cardiac-specific overexpression of G alpha q alters excitation-contractioncoupling in isolated cardiac myocytes, J MOL CEL C, 31(7), 1999, pp. 1327-1336

Authors: Sah, VP Minamisawa, S Tam, SP Wu, TH Dorn, GW Ross, J Chien, KR Brown, JH
Citation: Vp. Sah et al., Cardiac-specific overexpression of RhoA results in sinus and atrioventricular nodal dysfunction and contractile failure, J CLIN INV, 103(12), 1999, pp. 1627-1634

Authors: Small, K Feng, JF Lorenz, J Donnelly, ET Yu, A Im, MJ Dorn, GW Liggett, SB
Citation: K. Small et al., Cardiac specific overexpression of transglutaminase II (G(h)) results in aunique hypertrophy phenotype independent of phospholipase C activation, J BIOL CHEM, 274(30), 1999, pp. 21291-21296

Authors: Tepe, NM Lorenz, JN Yatani, A Dash, R Kranias, EG Dorn, GW Liggett, SB
Citation: Nm. Tepe et al., Altering the receptor-effector ratio by transgenic overexpression of type V adenylyl cyclase: Enhanced basal catalytic activity and function without increased cardiomyocyte beta-adrenergic signalling, BIOCHEM, 38(50), 1999, pp. 16706-16713
Risultati: 1-23 |